DepoMed Inc (ASRT) PT Lowered to $5 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ASRT Hot Sheet
Price: $23.50 --0%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst David Risinger lowered the price target on DepoMed Inc (NASDAQ: ASRT) to $5.00 (from $9.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
- CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
- Toronto-Dominion Bank (TD:CN) (TD) PT Raised to Cdn$184 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
